SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-164163
Filing Date
2019-06-03
Accepted
2019-06-03 16:41:03
Documents
5
Period of Report
2019-06-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d738925d8k.htm 8-K 26813
2 EX-10.1 d738925dex101.htm EX-10.1 25485
3 EX-99.1 d738925dex991.htm EX-99.1 3661
4 GRAPHIC g738925g31l57.jpg GRAPHIC 28924
5 GRAPHIC g738925g36g70.jpg GRAPHIC 3109
  Complete submission text file 0001193125-19-164163.txt   96190
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 19873820
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences